SG Americas Securities’s VolitionRx Ltd VNRX Stock Holding History

SG Americas Securities’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-636	Closed	-$49K	–	3495
2020 Q2	$49K	Buy	+636	New	+$45.9K	﹤0.01%	3539

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SG Americas Securities's VNRX Position: Q3 2020 in Review

SG Americas Securities sold out of VolitionRx Ltd (VNRX) in Q3 2020, closing a stake of 636 shares — an estimated $49K sold.

SG Americas Securities first reported a position in VNRX in Q2 2020 and held it in 1 quarter. The position peaked at $49K in Q2 2020. 47 funds tracked by Wall St. Rank hold VNRX as of Q3 2020.

SG Americas Securities reported no remaining VolitionRx Ltd position as of Q3 2020 after selling out during the quarter.
SG Americas Securities sold 636 VolitionRx Ltd shares in Q3 2020, an estimated $49K.
SG Americas Securities first reported a position in VolitionRx Ltd in Q2 2020 and held it in 1 quarter.
SG Americas Securities's VolitionRx Ltd position peaked at $49K in Q2 2020.
47 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.